Presented by Bristol Myers Squibb
Equity: How Digital Unlocks Access to Medicines
A personalized, human-centered approach to drug discovery and development has largely remained an unfulfilled promise. But after COVID-19 shed a light on disparities in health equity and access, digital is reshaping the biopharma industry: from pre-clinical data analysis to massive telemedicine growth to advancing diversity in clinical trial enrollment. Technologies like AI/ML combined with remote research and decentralized clinical trials help address health inequities and faster delivery of life-saving medicines to patients who need them most. This panel explores how rethinking the entire end-to-end drug development process drives greater speed, access, and equity. The panelists will also discuss ways to advance the industry through strategic partnerships.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.